Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;23(11):862-879.
doi: 10.1038/s41573-024-01026-y. Epub 2024 Sep 11.

Targeting cytokine networks in neuroinflammatory diseases

Burkhard Becher #  1 , Tobias Derfuss #  2 , Roland Liblau #  3
Affiliations
Review

Targeting cytokine networks in neuroinflammatory diseases

Burkhard Becher et al. Nat Rev Drug Discov. 2024 Nov.

Abstract

In neuroinflammatory diseases, systemic (blood-borne) leukocytes invade the central nervous system (CNS) and lead to tissue damage. A causal relationship between neuroinflammatory diseases and dysregulated cytokine networks is well established across several preclinical models. Cytokine dysregulation is also observed as an inadvertent effect of cancer immunotherapy, where it often leads to neuroinflammation. Neuroinflammatory diseases can be separated into those in which a pathogen is at the centre of the immune response and those of largely unknown aetiology. Here, we discuss the pathophysiology, cytokine networks and therapeutic landscape of 'sterile' neuroinflammatory diseases such as multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), neurosarcoidosis and immune effector cell-associated neurotoxicity syndrome (ICANS) triggered by cancer immunotherapy. Despite successes in targeting cytokine networks in preclinical models of neuroinflammation, the clinical translation of targeting cytokines and their receptors has shown mixed and often paradoxical responses.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Tuzlak, S. et al. Repositioning TH cell polarization from single cytokines to complex help. Nat. Immunol. 22, 1210–1217 (2021). - PubMed - DOI
    1. Zhou, Y., Zhang, K., Ma, X. & Xie, Z. Efficacy and safety of secukinumab for the treatment of psoriasis: a meta-analysis of pivotal phase III trials. Dermatology 240, 271–281 (2024). - PubMed - DOI
    1. Zwicky, P., Unger, S. & Becher, B. Targeting interleukin-17 in chronic inflammatory disease: a clinical perspective. J. Exp. Med. 217, e20191123 (2020). - PubMed - DOI
    1. Zipp, F., Bittner, S. & Schafer, D. P. Cytokines as emerging regulators of central nervous system synapses. Immunity 56, 914–925 (2023). - PubMed - PMC - DOI
    1. Mundt, S., Greter, M. & Becher, B. The CNS mononuclear phagocyte system in health and disease. Neuron 110, 3497–3512 (2022). - PubMed - DOI

Publication types

MeSH terms

LinkOut - more resources